Lara Milane - Concepedia

Author

Lara Milane

Northeastern University

Also Known As

Lara Milane, Lara S. Milane, Lara Scheherazade Milane

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Northeastern University Massachusetts General Hospital Sarcoma Oncology Center

About

Lara Milane is an author at Northeastern University specializing in radiation oncology, nanomedicine, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	210
2	Pharmacology	2	2	210
3	Engineering	1	1	88
4	Biomedical Engineering	1	1	88
5	Pathology	1	1	98

Lara Milane

Publications

864

Citations

H-Index

Page 1

	Year	Citations
Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells Lara Milane, Zhenfeng Duan, Mansoor M. Amiji Molecular Pharmaceutics	2010	158
Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma Michiro Susa, Arun K. Iyer, Keinosuke Ryu, PLoS ONE	2010	151
Label-Free Raman Spectral Imaging of Intracellular Delivery and Degradation of Polymeric Nanoparticle Systems T. V. Chernenko, Christian Matthäus, Lara Milane, ACS Nano	2009	129
Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning Lara Milane, Zhenfeng Duan, Mansoor M. Amiji Cancer Cell International	2011	117
Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer Lara Milane, Zhenfeng Duan, Mansoor M. Amiji Nanomedicine Nanotechnology Biology and Medicine NanomedicineBreast OncologyNanotherapeuticsDrug TargetingPolymer-drug Conjugate	2011	112
Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer Lara Milane, Zhenfeng Duan, Mansoor M. Amiji PLoS ONE NanotherapeuticsCombination NanoparticlesPathologyTumor BiologyNanomedicine	2011	98
Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer Xiaoqian Yang, Arun K. Iyer, Amit Singh, Pharmaceutical Research NanoparticlesNanomedicineMdr1 Sirna DeliveryEngineeringTherapeutic Nanomaterials	2014	88
Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer Lara Milane, Saket Dolare, Guangwen Ren, Journal of Controlled Release	2023	11

Page 1